Drug Trials Miss Groups Hardest Hit by Coronavirus, Study Says (2)

The black and Hispanic populations bearing the brunt of the coronavirus outbreak are also woefully underrepresented during clinical trials for drugs, a new study says.

The Food and Drug Administration has warned the lack of diversity in the large studies drug companies need to win approval means that research may miss how medications can affect some populations differently. Research released Tuesday by the Tufts Center for the Study of Drug Development found that women, blacks, and Hispanics participate in clinical trials at rates below their share of the U.S. population.

The study reinforces an existing problem in underrepresenting minorities in ...